Home

Home

795 results
  • intranet
  • deen

Martin-Immanuel Bittner

Medicine/Oncology
Year 2018

Arctoris

120E Olympic Avenue
Abingdon OX14 4SA
United Kingdom

T:
+44 7713 828 576

Trinity College

Broad Street
Oxford OX1 3BH
United Kingdom

T:
+44 1865 279 900
Portrait of Martin-Immanuel Bittner. He has short brown hair, blue eyes and wears a navy blue shirt.

Research areas

  • Oncology

  • Personalised medicine

  • Drug discovery

  • Machine Learning

  • Open Science

Projects
Research Groups

Resume

  • 2022
    Elected as Fellow of the Royal Society of Biology

  • 2022
    Elected as Fellow of the Institute of Biomedical Science

  • 2021
    Elected as Fellow of the Royal Society for Arts, Manufactures and Commerce

  • Since 2018
    Co-Founder & CEO, Arctoris; Old Member, Trinity College, Oxford

  • 2017-2018
    Junior Research Group Leader of the Fraunhofer Society, Stuttgart

  • 2017
    Doctor of Philosophy in Oncology, University of Oxford & Trinity College, Oxford

  • 2014-2017
    Doctoral research at the University of Oxford as Rhodes Scholar

  • 2014-2017
    Resident and Clinical Investigator at the University of Freiburg’s Medical Center

  • 2014
    Medical Licensing Examination; Full Licence to Practise; Doctorate of Medicine (magna cum laude), University of Freiburg

  • 2007-2014
    Medical student at the Universities of Frankfurt and Freiburg as Scholar of the German National Academic Foundation

Selection of
publications

  • Latest advances in aging research and drug discovery

    mit Bakula D, Ablasser A, Aguzzi A, Antebi A, Barzilai N, Jensen MB, Calkhoven CF, Chen D, Grey ADNJ, Feige JN, Georgievskaya A, Gladyshev VN, Golato T, Gudkov AV, Hoppe T, Kaeberlein M, Katajisto P, Kennedy BK, Lal U, Martin-Villalba A, Moskalev AA, Ozerov I, Petr MA, Reason, Rubinsztein DC, Tyshkovskiy A, Vanhaelen Q, Zhavoronkov A, Scheibye-Knudsen M. Aging (Albany NY). 2019 Nov 21;11.

  • Deep Learning: A Review for the Radiation Oncologist

    mit Boldrini L, Bibault JE, Masciocchi C, Shen Y. Front Oncol. 2019 Oct 1;9:977.

  • Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy

    mit Wiedenmann N, Bucher S, Hentschel M, Mix M, Rücker G, Weber WA, Meyer PT, Werner M, Grosu AL, Kayser G. Acta Oncol. 2016 Nov;55(11):1299-1304.

  • The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells

    mit Al-Assar O, Lunardi S, Stratford MR, McKenna WG, Brunner TB. Radiother Oncol. 2016 May;119(2):300-5.

  • Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome

    mit Wiedenmann NE, Bucher S, Hentschel M, Mix M, Vach W, Nestle U, Pfeiffer J, Weber WA, Grosu AL. Radiother Oncol. 2015 Oct;117(1):113-7.

  • Buchkapitel in Heatwaves and Health: Guidance on Warning-System Development

    mit Matthies F, Michelozzi P, Kovats S, Menne B. Heat and health. In: McGregor GR (Hsg): Heatwaves and Health: Guidance on Warning-System Development. World Meteorological Organization and World Health Organization, Genf 2015 (ISBN 978-92-63-11142-5)

  • Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer - a systematic review

    mit Grosu AL, Brunner TB. Radiother Oncol. 2015 Jan;114(1):117-21.

  • FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results

    Bilger A*, Grosu AL, Wiedenmann N, Meyer PT, Firat E, Niedermann G, Weber WA, Milanovic D. Strahlenther Onkol. 2014 Oct;190(10):957-61.

  • How is intensive care reimbursed? A review of eight European countries

    mit Donnelly M, van Zanten AR, Andersen JS, Guidet B, Trujillano Cabello JJ, Gardiner S, Fitzpatrick G, Winter B, Joannidis M, Schmutz A. 2013 Nov 12;3(1):37.

  • Auswirkungen von Hitzewellen auf die Mortalität in Deutschland

    Gesundheitswesen. 2014 Sep;76(8-9):508-12.

  • Are European countries prepared for the next big heat-wave?

    mit Matthies EF, Dalbokova D, Menne B. Eur J Public Health. 2014 Aug;24(4):615-9.

  • A systematic review of antiproton radiotherapy

    mit Grosu AL, Wiedenmann N, Wilkens JJ. Front Physics. 2014 Jan 16;1:37.

  • Hypoxia in Head and Neck Tumors: Characteristics and Development during Therapy

    mit Grosu AL. Front Oncol. 2013 Aug 28;3:223.

  • Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy

    mit Wiedenmann N, Bucher S, Hentschel M, Mix M, Weber WA, Grosu AL. Radiother Oncol. 2013 Sep;108(3):511-6.

  • Information technology in radiation oncology - a brave new world?

    Front Oncol. 2013 May 10;3:116.

  • Heat-related mortality in Freiburg and Rostock in 2003 and 2005 - methodology and results

    mit Nübling M, Stössel U. Gesundheitswesen. 2013 Aug;75(8-9):e126-30.

  • Perceptions of heatwave risks to health: results of an qualitative interview study with older people and their carers in Freiburg, Germany

    mit Stößel U. Psychosoc Med. 2012;9:Doc05.

  • Gefährdung älterer Menschen durch Hitzewellen in exponierten Städten

    mit Stößel U. Public Health Forum. 2012;20(75):25-27.

  • Latest advances in aging research and drug discovery

    mit Bakula D, Ablasser A, Aguzzi A, Antebi A, Barzilai N, Jensen MB, Calkhoven CF, Chen D, Grey ADNJ, Feige JN, Georgievskaya A, Gladyshev VN, Golato T, Gudkov AV, Hoppe T, Kaeberlein M, Katajisto P, Kennedy BK, Lal U, Martin-Villalba A, Moskalev AA, Ozerov I, Petr MA, Reason, Rubinsztein DC, Tyshkovskiy A, Vanhaelen Q, Zhavoronkov A, Scheibye-Knudsen M. Aging (Albany NY). 2019 Nov 21;11.

  • Deep Learning: A Review for the Radiation Oncologist

    mit Boldrini L, Bibault JE, Masciocchi C, Shen Y. Front Oncol. 2019 Oct 1;9:977.

Activities